EP Patent

EP3861986A1 — Pharmaceutical compositions comprising polypeptides and related methods of delivery

Assigned to Amryt Endo Inc · Expires 2021-08-11 · 5y expired

What this patent protects

The invention relates to a composition comprising a suspension which comprises an admixture of a hydrophobic medium and a solid form wherein the solid form comprises a therapeutically effective amount of a therapeutic agent and at least one salt of a medium chain fatty acid, and …

USPTO Abstract

The invention relates to a composition comprising a suspension which comprises an admixture of a hydrophobic medium and a solid form wherein the solid form comprises a therapeutically effective amount of a therapeutic agent and at least one salt of a medium chain fatty acid, and wherein the medium chain fatty acid salt is present in the composition at an amount of 10% or more by weight, wherein the therapeutic agent is a polypeptide. The invention also relates to compositions for use in treating or preventing diseases by administration of the compositions to affected subj ects.

Drugs covered by this patent

Patent Metadata

Patent number
EP3861986A1
Jurisdiction
EP
Classification
Expires
2021-08-11
Drug substance claim
No
Drug product claim
No
Assignee
Amryt Endo Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.